Literature DB >> 25935211

The Economic and Humanistic Burden of Severe Sepsis.

Bogdan Tiru1, Ernest K DiNino, Abigail Orenstein, Patrick T Mailloux, Adam Pesaturo, Abhinav Gupta, William T McGee.   

Abstract

Sepsis and severe sepsis in particular remain a major health problem worldwide. Their cost to society extends well beyond lives lost, as the impact of survivorship is increasingly felt. A review of the medical literature was completed in MEDLINE using the search phrases "severe sepsis" and "septic shock" and the MeSH terms "epidemiology", "statistics", "mortality", "economics", and "quality of life". Results were limited to human trials that were published in English from 2002 to 2014. Articles were classified by dominant themes to address epidemiology and outcomes, including quality of life of both patient and family caregivers, as well as societal costs. The severity of sepsis is determined by the number of organ failures and the presence of shock. In most developed countries, severe sepsis and septic shock account for disproportionate mortality and resource utilization. Although mortality rates have decreased, overall mortality continues to increase and is projected to accelerate as people live longer with more chronic illness. Among those who do survive, impaired quality of life, increased dependence, and rehospitalization increase healthcare consumption and, along with increased mortality, all contribute to the humanistic burden of severe sepsis. A large part of the economic burden of severe sepsis occurs after discharge. Initial inpatient costs represent only 30 % of the total cost and are related to severity and length of stay, whereas lost productivity and other indirect medical costs following hospitalization account for the majority of the economic burden of sepsis. Timeliness of treatment as well as avoidance of intensive care unit (ICU)-acquired illness/morbidity lead to important differences in both cost and outcome of treatment for severe sepsis and represent areas where improvement in care is possible. The degree of sophistication of a health system from a national perspective results in significant differences in resource use and outcomes for patients with serious infections. Comprehensive understanding of the cost and humanistic burden of severe sepsis provides an initial practical framework for health policy development and resource use.

Entities:  

Mesh:

Year:  2015        PMID: 25935211     DOI: 10.1007/s40273-015-0282-y

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  90 in total

1.  Comparison of two fluid-management strategies in acute lung injury.

Authors:  Herbert P Wiedemann; Arthur P Wheeler; Gordon R Bernard; B Taylor Thompson; Douglas Hayden; Ben deBoisblanc; Alfred F Connors; R Duncan Hite; Andrea L Harabin
Journal:  N Engl J Med       Date:  2006-05-21       Impact factor: 91.245

Review 2.  Critically ill cancer patient in intensive care unit: issues that arise.

Authors:  Eirini Kostakou; Nikoletta Rovina; Magdalini Kyriakopoulou; Nikolaos G Koulouris; Antonia Koutsoukou
Journal:  J Crit Care       Date:  2014-04-24       Impact factor: 3.425

3.  Post-ICU mortality in critically ill infected patients: an international study.

Authors:  Elie Azoulay; Corinne Alberti; Isabelle Legendre; Christian Brun Buisson; Jean Roger Le Gall
Journal:  Intensive Care Med       Date:  2004-11-04       Impact factor: 17.440

4.  Epidemiology, surveillance, and prevention of bloodstream infections in hemodialysis patients.

Authors:  Priti R Patel; Alexander J Kallen; Matthew J Arduino
Journal:  Am J Kidney Dis       Date:  2010-06-15       Impact factor: 8.860

5.  The costs of septic syndromes in the intensive care unit and influence of hospital-acquired sepsis.

Authors:  Christian Brun-Buisson; Françoise Roudot-Thoraval; Emmanuelle Girou; Catherine Grenier-Sennelier; Isabelle Durand-Zaleski
Journal:  Intensive Care Med       Date:  2003-07-10       Impact factor: 17.440

6.  Incidence of and mortality due to sepsis, severe sepsis and septic shock in Italian Pediatric Intensive Care Units: a prospective national survey.

Authors:  Andrea Wolfler; Paolo Silvani; Massimo Musicco; Massimo Antonelli; Ida Salvo
Journal:  Intensive Care Med       Date:  2008-05-24       Impact factor: 17.440

7.  Bacteremia in blood or marrow transplantation patients: clinical risk factors for infection and emerging antibiotic resistance.

Authors:  Allison M Bock; Qing Cao; Patricia Ferrieri; Jo-Anne H Young; Daniel J Weisdorf
Journal:  Biol Blood Marrow Transplant       Date:  2012-08-29       Impact factor: 5.742

Review 8.  Sepsis and septic shock: progress and future considerations.

Authors:  Peter Skippen; Niranjan Kissoon; David Waller; Tracie Northway; Gordon Krahn
Journal:  Indian J Pediatr       Date:  2008-08-31       Impact factor: 1.967

Review 9.  Critical care and the global burden of critical illness in adults.

Authors:  Neill K J Adhikari; Robert A Fowler; Satish Bhagwanjee; Gordon D Rubenfeld
Journal:  Lancet       Date:  2010-10-11       Impact factor: 79.321

10.  How much does it cost to care for survivors of colorectal cancer? Caregiver's time, travel and out-of-pocket costs.

Authors:  Paul Hanly; Alan Ó Céilleachair; Mairead Skally; Eamonn O'Leary; Kanika Kapur; Patricia Fitzpatrick; Anthony Staines; Linda Sharp
Journal:  Support Care Cancer       Date:  2013-05-07       Impact factor: 3.603

View more
  33 in total

1.  Improving clinical outcomes in sepsis and multiple organ dysfunction through precision medicine.

Authors:  Sanjay Mehta; Sean E Gill
Journal:  J Thorac Dis       Date:  2019-01       Impact factor: 2.895

2.  Outcomes of severe sepsis and septic shock patients after stratification by initial lactate value.

Authors:  Kimberly A Chambers; Adam Y Park; Rosa C Banuelos; Bryan F Darger; Bindu H Akkanti; Annamaria Macaluso; Manoj Thangam; Pratik B Doshi
Journal:  World J Emerg Med       Date:  2018

Review 3.  Cerebral Blood Flow Autoregulation in Sepsis for the Intensivist: Why Its Monitoring May Be the Future of Individualized Care.

Authors:  Carrie M Goodson; Kathryn Rosenblatt; Lucia Rivera-Lara; Paul Nyquist; Charles W Hogue
Journal:  J Intensive Care Med       Date:  2016-10-25       Impact factor: 3.510

4.  Evaluation of the Association of Early Elevated Lactate With Outcomes in Children With Severe Sepsis or Septic Shock.

Authors:  Noelle Gorgis; Jeannette M Asselin; Cynthia Fontana; R Scott Heidersbach; Heidi R Flori; Shan L Ward
Journal:  Pediatr Emerg Care       Date:  2019-10       Impact factor: 1.454

5.  Dynamic changes in human single-cell transcriptional signatures during fatal sepsis.

Authors:  Xinru Qiu; Jiang Li; Jeff Bonenfant; Lukasz Jaroszewski; Aarti Mittal; Walter Klein; Adam Godzik; Meera G Nair
Journal:  J Leukoc Biol       Date:  2021-09-24       Impact factor: 4.962

6.  Th17, rather than Th1 cell proportion, is closely correlated with elevated disease severity, higher inflammation level, and worse prognosis in sepsis patients.

Authors:  Yu Liu; Xiaopin Wang; Li Yu
Journal:  J Clin Lab Anal       Date:  2021-03-11       Impact factor: 2.352

7.  Therapeutic Potential of Extracellular Vesicles for Sepsis Treatment.

Authors:  Stephanie M Kronstadt; Alex E Pottash; Daniel Levy; Sheng Wang; Wei Chao; Steven M Jay
Journal:  Adv Ther (Weinh)       Date:  2021-04-29

8.  Associations of Intensive Care Unit Capacity Strain with Disposition and Outcomes of Patients with Sepsis Presenting to the Emergency Department.

Authors:  George L Anesi; Vincent X Liu; Nicole B Gabler; M Kit Delgado; Rachel Kohn; Gary E Weissman; Brian Bayes; Gabriel J Escobar; Scott D Halpern
Journal:  Ann Am Thorac Soc       Date:  2018-11

9.  NETIMIS: Dynamic Simulation of Health Economics Outcomes Using Big Data.

Authors:  Owen A Johnson; Peter S Hall; Claire Hulme
Journal:  Pharmacoeconomics       Date:  2016-02       Impact factor: 4.981

10.  Heart Rate Variability in Porcine Progressive Peritonitis-Induced Sepsis.

Authors:  Dagmar Jarkovska; Lenka Valesova; Jiri Chvojka; Jan Benes; Jitka Sviglerova; Blanka Florova; Lukas Nalos; Martin Matejovic; Milan Stengl
Journal:  Front Physiol       Date:  2016-01-06       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.